Tiziana Life Sciences develops foralumab for treating neurodegenerative diseases like SPMS and Alzheimer's, with promising ...

Tata Capital, the financial services arm of the Tata Group, has started preparations for a $2 billion initial public offering ...

Anavex Life Sciences remains one of the few non-amyloid Alzheimer's drug developers. Find out why I rate AVXL stock as a Hold ...

The potential payoff is great, but family life disruption and an unfamiliar living environment are big hurdles. Read more at straitstimes.com.

Indian startups saw over $5 billion in exits through secondary transactions, IPOs, and block deals in 2024. This trend is ...

Analysts at Keefe, Bruyette & Woods (KBW) are the second group to say that the returns generated from catastrophe reinsurance ...

See how we rate investing products to write unbiased product reviews. The U.S. stock market generally closes for major holidays like Memorial Day, Independence Day, and Thanksgiving. But not all ...

2-Year U.S. Treasury Note Continuous Contract $102.629-0.008-0.01% 5-Year U.S. Treasury Note Continuous Contract $106.016-0.047-0.04% 10-Year U.S. Treasury Note Continuous Contract $108.422-0.047 ...

The company announced in an exchange filing that it has obtained a letter of intent (LOI) for a new contract worth ₹1,200 Crore in Gujarat.

Deven Choksey highlights investment opportunities amid market corrections and anticipates stronger public sector banks if interest rates drop. EMS stocks may be better bought on dips. The pharma ...

Stock Market Crash: Nifty’s worst week of 2024 – top 10 losers ...